Evidence map›Paper›PMID 39796749›Full record

ArticleCancers2025

Advanced Brain Tumor Classification in MR Images Using Transfer Learning and Pre-Trained Deep CNN Models.

Rukiye Disci, Fatih Gurcan, Ahmet Soylu

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. [Application of hybrid attention guided dual-path residual learning in magnetic resonance imaging diagnosis].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rukiye DisciDepartment of Management Information Systems, Faculty of Economics and Administrative Sciences, Karadeniz Technical University, 61080 Trabzon, Turkey.
Fatih GurcanDepartment of Management Information Systems, Faculty of Economics and Administrative Sciences, Karadeniz Technical University, 61080 Trabzon, Turkey.ORCID 0000-0001-9915-6686
Ahmet SoyluDepartment of Computer Science, Faculty of Information Technology and Electrical Engineering, Norwegian University of Science and Technology, 2815 Gjøvik, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesBrain tumor classification is a crucial task in medical diagnostics, as early and accurate detection can significantly improve patient outcomes. This study investigates the effectiveness of pre-trained deep learning models in classifying brain MRI images into four categories: Glioma, Meningioma, Pituitary, and No Tumor, aiming to enhance the diagnostic process through automation.

methodsA publicly available Brain Tumor MRI dataset containing 7023 images was used in this research. The study employs state-of-the-art pre-trained models, including Xception, MobileNetV2, InceptionV3, ResNet50, VGG16, and DenseNet121, which are fine-tuned using transfer learning, in combination with advanced preprocessing and data augmentation techniques. Transfer learning was applied to fine-tune the models and optimize classification accuracy while minimizing computational requirements, ensuring efficiency in real-world applications.

resultsAmong the tested models, Xception emerged as the top performer, achieving a weighted accuracy of 98.73% and a weighted F1 score of 95.29%, demonstrating exceptional generalization capabilities. These models proved particularly effective in addressing class imbalances and delivering consistent performance across various evaluation metrics, thus demonstrating their suitability for clinical adoption. However, challenges persist in improving recall for the Glioma and Meningioma categories, and the black-box nature of deep learning models requires further attention to enhance interpretability and trust in medical settings.

conclusionsThe findings underscore the transformative potential of deep learning in medical imaging, offering a pathway toward more reliable, scalable, and efficient diagnostic tools. Future research will focus on expanding dataset diversity, improving model explainability, and validating model performance in real-world clinical settings to support the widespread adoption of AI-driven systems in healthcare and ensure their integration into clinical workflows.

Indexed as

brain tumor classificationclinical diagnosticsdeep learningmodel performanceMR imagingtransfer learning

Identifiers

PMID39796749
PMCPMC11719945

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.